Implications of the changing regulatory environment in India
Abstract:
Government policy towards the biopharma industry has become steadily more favourable, making India an attractive destination for biopharma outsourcing and its allied activities. This chapter discusses the plans which have been, and are likely to be, implemented by the government of India and how they will benefit the growth of the industry. These plans include incentives, tax deductions and the further liberalisation of foreign investment for those entities entering the industry. The chapter further discusses the role of the state and central governments in the regulatory framework, with a focus on the ethical considerations which entities should take into account. Proposed ...
Get Outsourcing Biopharma R&D to India now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
